Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/24156
Authors: 
Fier, Andreas
Heneric, Oliver
Year of Publication: 
2005
Series/Report no.: 
ZEW Discussion Papers 05-60
Abstract: 
The German biotechnology industry missed the accession of this key technology in the 1980s. Policy makers make different efforts to overcome shortcomings and recent gaps. Public funding schemes have been implemented to establish a flourish biotech industry in Germany. We assume that R&D policy was driven blind by the idea to catch up with world?s biotech leaders and analyse if Germany?s R&D policy lost its origins. We do examine, if Germany sacrifice economic funding principles, in particular not discriminating different kinds of ?risk? in the field of biotechnology. The study combines survey data of German biotech companies and public R&D funding data on the firm level. The results shed light on the factors which determine public R&D funding and firm?s probability of being funded.
Subjects: 
Biotechnology
Public Policy
Innovation
Subsidies
JEL: 
C21
L21
H32
M13
L65
O38
Document Type: 
Working Paper

Files in This Item:
File
Size
186.5 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.